Chief Scientific Officer

Tim has over 19 years experience of working in industry, on a wide range of antibody and small molecule projects in immunology and oncology. After obtaining a PhD in Immunology at the National Institute for Medical Research, London and completing post-doctoral studies on immunoregulation, Tim joined Celltech in 1997. During his time at Celltech, he was responsible for the non-clinical development of two antibody programs that entered the clinic. After the acquisition of Celltech by UCB, Tim contributed to the successful licensing submissions for Cimzia as well as to multiple antibody programs that entered development. More recently, he led one of UCB’s small molecule programs. Tim joined Step Pharma in January 2017.